Cardio-Oncology Clinic Established at The Mount Sinai Hospital
April 15, 2014
Cardiologists and cancer experts at The Mount Sinai Hospital have joined forces to establish its first Cardio-Oncology Clinic at The Tisch Cancer Institute.
The American Society of Clinical Oncology Awards Quality Certification to Mount Sinai’s GI Medical Oncology Program at The Tisch Cancer Institute
October 30, 2013
Mount Sinai is the first only site in Manhattan with a QOPI®-certified practice.
Mount Sinai Oncologists Improve Quality of Care for Cancer Patients with Standardized Criteria for Palliative Care Consultation
October 29, 2013
Intervention doubled palliative care consultations; lowered in-hospital mortality and hospital readmission rates.
Mount Sinai Researchers Identify Mechanisms and Potential Biomarkers of Tumor Cell Dormancy
October 28, 2013
May be able to recreate conditions that keep cancer cells from growing after they have spread.
Mount Sinai Receives NIH Grant to Increase the Engagement of African Americans in Colorectal Cancer Screening
September 4, 2013
Mount Sinai researchers have received a grant from the NIH to determine why African Americans are less likely than others to receive colorectal cancer screenings.
The Mount Sinai Medical Center Recognized by U.S. News and World Report in Annual “Best Hospitals” Rankings
July 16, 2013
The Mount Sinai Medical Center is prominently featured in U.S. News & World Report’s clinical specialty ranking of the nation’s most outstanding hospitals.
400 Individuals Received Complimentary On-Site Melanoma Screenings at 2013 Aspen Ideas Festival
July 3, 2013
Mount Sinai dermatologists identified several melanomas and non-melanoma skin cancers at the screening.
The Mount Sinai Medical Center Will Participate in the Aspen Ideas Festival
June 24, 2013
Kenneth Davis, MD, President and CEO of The Mount Sinai Medical Center, to speak on the future of medicine at the Aspen Ideas Festival in Colorado
Gene Variant May Provide Novel Therapy for Several Cancer Types
June 6, 2013
A novel gene variant found in human and animal tissue may be a promising treatment for cancer, including breast and brain cancer.
Mount Sinai Researchers to Present Landmark Studies at American Society of Clinical Oncology Meeting
June 1, 2013
Mount Sinai researchers present new data on HPV oral infection and melanoma predictors at ASCO
Sarcoma Foundation of America Honors Robert G. Maki, MD, PhD, with the Nobility in Science Award
April 29, 2013
Dr. Maki was recognized for his committment to finding a cure for sarcoma, a cancer of the connective tissue including bone, cartilage, muscle, and fat.
Mount Sinai Launches Phase III Clinical Trial of Novel, Personalized Vaccine for Newly-Diagnosed Kidney Cancer
April 17, 2013
Study will examine potential of investigational immunotherapy AGS-003 to improve survival when combined with standard kidney cancer treatment.
Soy-Based Compound May Reduce Tumor Cell Proliferation In Colorectal Cancer
April 11, 2013
Mount Sinai presented new research in several cancer types at the American Association for Cancer Research Annual Meeting
Ramon Parsons, MD, PhD, Named Chair of Oncological Sciences at the Icahn School of Medicine at Mount Sinai
March 6, 2013
Stuart Aaronson, MD, will continue conducting transformative research at Mount Sinai as Founding Chair, Emeritus
Protein Lost in Tumors Blocks Normal Cells From Being Reprogrammed into Stem Cells
March 5, 2013
Mount Sinai researchers identify mechanism that prevents cells from being reprogrammed into embryonic stem cells
Head Caps with Electrodes May Treat Brain Cancer
February 25, 2013
Patients with aggressive brain tumors may be treated with a head cap that produces changes in electrical fields, as part of a clinical trial at Mount Sinai.
Leon and Norma Hess Center for Science and Medicine Opens at Mount Sinai
December 13, 2012
The state-of-the-art facility expands research capacity, fosters real-time collaboration; Mount Sinai also unveils a new brand and logo
New Six-Gene Signature Can Predict Prostate Cancer Survival
October 9, 2012
Mount Sinai researchers have identified a six-gene model that determines prognosis in men with treatment-resistant prostate cancer.
Mount Sinai School of Medicine Researchers Awarded “Provocative Questions” Grant from National Cancer Institute
September 20, 2012
Researchers are among a select group of scientists who have been recognized for their quest to answer the most pressing questions about cancer.
Mount Sinai Researchers Unveil New Chemotherapy-Resistant Cancer Stem Cell
September 10, 2012
Scientists have discovered cells that display cancer stem cell properties and resistance to chemotherapy, and participate in tumor progression.
Mount Sinai Presents Research on Robotic Surgery and HPV at Head and Neck Cancer Meeting
July 25, 2012
Benefits of robotic surgery in smokers and nonsmokers and predictors of HPV-positive head and neck cancer presented at the 8th International Conference on Head and Neck Cancer.
Mount Sinai Researchers Present Studies On Treatment Trends, Myeloma Vaccine, and Predictive Models at Cancer Meeting
May 17, 2012
Access to care, vaccine, treatment trends among landmark research at the 2012 American Society of Clinical Oncology meeting.
Radiation After Surgery Does Not Extend Survival in Lung Cancer Subtype
February 13, 2012
Mount Sinai researchers have found that post-operative radiation therapy does not improve outcomes in older patients with locally advanced lung cancer.
Chef Floyd Cardoz Wins Top Chef Masters and 100,000 Dollars on Behalf of Mount Sinai
June 16, 2011
Chef Cardoz won Top Chef Master’s grand prize of $100,000 on behalf of The Tisch Cancer Institute’s Young Scientist Cancer Research Fund at Mount Sinai.
Alisan Goldfarb, MD Receives Prestigious Award from American Cancer Society
May 24, 2011
Dr. Goldfarb was recognized with the Physician of Distinction Award for outstanding contributions to clinical care in breast cancer
Dubin Breast Center Now Offers Cutting-Edge 3D Mammography Technology
May 9, 2011
The Dubin Breast Center of The Tisch Cancer Institute is one of the first centers in the country to offer 3D mammography, allowing for earlier and more accurate breast cancer diagnosis.
Researchers Estimate Environmentally-Induced Childhood Disease Cost At $76.6 Billion
May 4, 2011
New data show that, despite previous efforts to curb their use, toxic chemicals have a major impact on health care costs and childhood morbidity.
Carlos Cordon-Cardo, MD, PhD Named Chair of Department of Pathology at The Mount Sinai Medical Center
April 4, 2011
Dr. Cordon-Cardo, an expert in experimental pathology and molecular oncology, joins Mount Sinai as Chair of the Department of Pathology.
Mount Sinai Celebrates the “Topping Off” of the New Center for Science and Medicine Building
February 7, 2011
Set to open in 2012, CSM will bring nearly a half-million square-feet of new, state-of-the-art medical research and clinical facilities to Mount Sinai.
Researchers from Mount Sinai School of Medicine Make Major Breakthrough in Melanoma Research
December 22, 2010
A discovery made by Mount Sinai researchers about the progression of melanoma could lead to new treatments.
Mount Sinai Appoints Robert Maki, MD, PhD, As New Chief of Pediatric Hematology Oncology
December 14, 2010
Dr. Robert Maki named Mount Sinai Chief of Pediatric Hematology/Oncology and Medical Director, Sarcoma Cancer Program, at The Tisch Cancer Institute.
Dr. AnaLisa DiFeo Recognized As Liz Tilberis Scholar for Ovarian Cancer Research
December 1, 2010
AnaLisa DiFeo honored with the Liz Tilberis Grant from the Ovarian Cancer Research Fund to support her research on chemoresistance in ovarian cancer.
Conference to Explore Latest Screening Methods and Treatments for Lung Cancer
October 21, 2010
23rd International Conference on Screening for Lung Cancer To Be Held at The Mount Sinai Medical Center October 22 and 23
The Mount Sinai Medical Center Appoints Randall F. Holcombe, MD As Director of Clinical Cancer Affairs
September 24, 2010
Dr. Randall Holcombe has joined Mount Sinai as Director of Clinical Cancer Affairs and Director of Gastrointestinal Medical Oncology.
Dr. Marshall Posner Leads the Head and Neck Oncology Program at Mount Sinai
July 27, 2010
As the medical director, Dr. Posner will lead an interdisciplinary collaboration with surgery and continue his research on viral-driven solid tumor oncology.
Jia Chen, ScD, Receives Visiting Scientist Award from International Agency for Research on Cancer
June 14, 2010
Dr. Chen will spend the 2010/2011 academic year continuing her research on breast and lung cancer with collaborators at IARC in Lyon, France.
Sundar Jagannath, MD, Named Director of Multiple Myeloma Program at Mount Sinai School of Medicine
June 1, 2010
Blood cancer expert Sundar Jagannath, MD, will join The Mount Sinai Medical Center as Director of the Multiple Myeloma Program.
Elisa R. Port, MD, FACS, Named Chief of Breast Surgery at Mount Sinai School of Medicine
April 22, 2010
Renowned surgeon Elisa R. Port, MD, FACS, returns as Chief of Breast Surgery and Co-Director of the Dubin Breast Center.
Robotic Prostatectomy Minimizes Surgery, Reduces Recovery Time, and Shortens Hospital Stays
April 15, 2010
Recent Mount Sinai study shows significant benefits to robotically assisted procedures over open prostate surgery.
William K. Oh, MD, Joins The Mount Sinai Medical Center As Chief of the Division of Hematology and Medical Oncology
September 16, 2009
William K. Oh, MD, is known for his expertise in using biological data banks to advance the understanding of cancer and cancer treatment.
Mount Sinai's State-of-the-Art Prostate Cancer Center Targets Quality of Life for Patients Undergoing Robotic Surgery
May 13, 2009
The resource center for prostate cancer care, led by David B. Samadi, MD, Chief of the Division of Robotics and Minimally Invasive Surgery, specializes in pre- and postsurgical care.